CN112662573B - Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof - Google Patents

Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof Download PDF

Info

Publication number
CN112662573B
CN112662573B CN202011562000.2A CN202011562000A CN112662573B CN 112662573 B CN112662573 B CN 112662573B CN 202011562000 A CN202011562000 A CN 202011562000A CN 112662573 B CN112662573 B CN 112662573B
Authority
CN
China
Prior art keywords
gene
strain
acid
ornithine
sida
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011562000.2A
Other languages
Chinese (zh)
Other versions
CN112662573A (en
Inventor
池哲
池振明
孔存翠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocean University of China
Original Assignee
Ocean University of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean University of China filed Critical Ocean University of China
Priority to CN202011562000.2A priority Critical patent/CN112662573B/en
Publication of CN112662573A publication Critical patent/CN112662573A/en
Application granted granted Critical
Publication of CN112662573B publication Critical patent/CN112662573B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of genetic engineering, and discloses a microbial strain for efficiently synthesizing L-piperazinic acid, a construction method and application thereof. The microbial strain provided by the invention is used for further transforming a vector containing an L-piperazines synthetase encoding gene ktzT or hmtC in a aureobasidium pullulans D-OLCF strain for producing melanin, or integrating the L-piperazines synthetase encoding gene ktzT or hmtC into a genome of the aureobasidium pullulans D-OLCF strain for producing melanin. The invention selects an appropriate source of L-piperazine acid synthetase gene, constructs a microbial strain with high L-piperazine acid yield, and can further promote the L-piperazine acid yield by introducing the inhibition of iron ions to be removed by the L-ornithine hydroxylase coding gene SidA; the L-piperazine acid is directly produced by converting the fermentation raw material by the microbial strain provided by the invention, the synthesis process does not need to depend on a chemically synthesized platform compound, the reaction condition is mild and easy to control, and the method is environment-friendly.

Description

Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a microbial strain for efficiently synthesizing L-piperazinic acid and a construction method and application thereof.
Background
Piperazine acid is a unique non-protein amino acid containing a nitrogen-nitrogen (N-N) bond. Piperazinoic acid is present in many natural products with significant biological activity, such as the natural immunosuppressant sanglifehrin (a) and the antitumor active peptide luzoneptins (luzopeptins). Piperazine acid is a first-line antihypertensive drug cilazapril
Figure BDA0002860959770000011
A synthetic precursor. Furthermore, the piperazine acid has a structurally rigid conformation, which makes it possible to introduce, as building blocks, β -turn structures in peptide synthesis. These unique properties have motivated synthetic chemists to devote their efforts to the development of chemical synthetic pathways for piperazine acids as important intermediates in the synthesis of drugs and chemicals. Thus, the compound was investigatedThe high-efficiency synthesis of the compound has important and wide significance.
Over the last few years, the pure stereoselective specific synthesis of piperazinic acids and the piperazinic acid building blocks within the macromolecular chemical building blocks have received increasing attention. The piperazinic acid can be synthesized by two methods, wherein one method takes a chiral compound as an initial raw material, such as L- (+) glutamic acid, and the compound is obtained by nine-step synthesis, and the method has the advantages of long line, high cost, complex process, high reaction difficulty and lower total yield (less than 30%); the second method is to use an achiral compound as a raw material and perform Diels-Alder reaction, although the process is relatively simple and the yield is high, the obtained product is racemic and needs to be subjected to chemical resolution, and common chemical resolving agents are expensive.
The biotransformation method can overcome the defects, the reaction of biotransformation of piperazine acid directly converts the fermentation raw material to produce the compound, the synthesis process does not need to depend on a chemically synthesized platform compound, the reaction condition is mild and easy to control, and the method is environment-friendly. Therefore, how to efficiently synthesize the piperazine acid by a biological method is a key technical problem to be solved by the invention.
Disclosure of Invention
In view of the above, the present invention aims to provide a microbial strain for efficiently synthesizing L-piperazinic acid and a construction method thereof, such that the microbial strain can be used to obtain a very high yield of L-piperazinic acid;
the invention also aims to provide the application of the microbial strain in the fermentation production of L-piperazinic acid or the preparation of a microbial product for the fermentation production of L-piperazinic acid;
another object of the present invention is to provide a method for producing L-piperazinic acid by fermentation using the microorganism strain.
In order to achieve the above purpose, the invention provides the following technical scheme:
a microbial strain for efficiently synthesizing L-piperazinic acid is characterized in that a carrier containing an L-piperazinic acid synthetase encoding gene ktzT or hmtC is further transformed in an aureobasidium melanoidinum D-OLCF strain, or the L-piperazinic acid synthetase encoding gene ktzT or hmtC is integrated into a genome of the aureobasidium melanoidinum D-OLCF strain;
the aureobasidium pullulans D-OLCF (hereinafter referred to as DF1) is a compound which has a preservation number of CCTCC NO: knock-out of ornithine carbamoyl transferase gene OTC and L-ornithine-N on the basis of Aureobasidium melanogenin HN6.2 strain of M2020340 5 Transacetylase gene sidL, FC synthetase gene sidC and L-ornithine-N 5 -a strain of the hydroxy-transacetylase gene sidF.
Preferably, the L-piperazine synthetase encoding gene ktzT is derived from Kutzneria sp.744; the gene hmtc encoding the L-piperazine synthetase is derived from Streptomyces himastatinicus ATCC 53653. In a specific embodiment of the present invention, the sequence of the coding gene ktzT of L-piperazinic acid synthetase derived from Kutzneria sp.744 is shown in SEQ ID NO. 1, and the coding gene hmtc of L-piperazinic acid synthetase derived from Streptomyces himastatinicus ATCC 53653 is shown in SEQ ID NO. 2.
In order to further improve the yield of the microbial strains, the method also comprises knocking out the original L-ornithine hydroxylase coding gene sidA in DF1 and converting a vector containing the L-ornithine hydroxylase coding gene SidA shown in SEQ ID NO. 8; or replacing the original L-ornithine hydroxylase coding gene sidA with the L-ornithine hydroxylase coding gene sidA shown in SEQ ID NO. 8 in the DF1 genome. When transforming a vector containing the L-ornithine hydroxylase encoding gene SidA, SidA can be introduced into the same vector as ktzT or hmtc for efficiency reasons.
In the concrete embodiment of the invention, the invention also provides L-piperazine synthetase encoding genes derived from Streptomyces flaveolus DSM9954, Streptomyces sp, Actinomanda atramentaria DSM 43919 and Pseudonocardia sp.HH130629-09, which are sfAC, padO, matF and XF36 in sequence, and the sequences are shown as SEQ ID NO:3-6 in sequence; the microbial strain has the L-piperazinic acid yield of more than 150mg/L, and has very obvious yield advantage compared with the microbial strain constructed by the genes.
Based on the above, the invention provides the application of the microbial strain in fermentation production of L-piperazinic acid or the application in preparation of a microbial product for fermentation production of L-piperazinic acid.
Meanwhile, the invention also provides a construction method of the microbial strain, which comprises the steps of constructing a vector containing the L-piperazinic acid synthetase encoding gene ktztT or hmtc, and then transforming the vector into DF1 to obtain the microbial strain. In addition, the coding gene ktztt or hmtc can be integrated directly into the DF1 genome by prior art methods, for example, by constructing upstream and downstream homology arms for integration by yeast homologous recombination.
In the construction process, the original gene sidA of L-ornithine hydroxylase in DF1 can be further knocked out and a vector containing the gene SidA of L-ornithine hydroxylase coding shown in SEQ ID NO. 8 can be transformed; or replacing the original L-ornithine hydroxylase coding gene sidA with the L-ornithine hydroxylase coding gene SidA shown in SEQ ID NO. 8 in the DF1 genome; in transforming vectors containing the L-ornithine hydroxylase encoding gene SidA, SidA can be introduced into the same vector as ktzT or hmtc for efficiency reasons.
In a specific embodiment of the invention, the vector is pAMEXloxp-1 plasmid.
In addition, the invention also provides a method for producing L-piperazinic acid by fermentation, namely inoculating the microbial strain to a piperazinic acid production medium to produce L-piperazinic acid by fermentation.
Preferably, the piperazine acid producing medium is a CM medium; in a specific embodiment of the invention, the CM medium is: 10-50 g/L glucose, 10-30g/L peptone, 1-5 g/L dipotassium hydrogen phosphate, 1-2 g/L citric acid monohydrate, 1-5 g/L YNB, 0.01-0.1 g/L magnesium sulfate, 0.001-0.005 g/L zinc sulfate, and pH 6-7.
Preferably, the fermentation is carried out at 28 ℃ and 180rpm for 120 h.
According to the technical scheme, the L-piperazinic acid synthetase gene with a proper source is selected, the microbial strain with high L-piperazinic acid yield is constructed, and the inhibition of iron ions can be further improved by introducing the coding gene SidA of the L-ornithine hydroxylase to decompose the iron ions; the L-piperazine acid is directly produced by converting the fermentation raw materials by the microbial strains provided by the invention, the synthesis process does not need to depend on a chemically synthesized platform compound, the reaction condition is mild and easy to control, and the method is environment-friendly. The method solves the problems of low stereoselectivity, serious pollution, complex process, high cost, low yield and the like caused by a chemical production method.
Biological material preservation information description
And (3) classification and naming: aureobasidium melanogenoum HN6.2, which has been deposited with the China center for type culture Collection on 23/7/2020, addresses: china, Wuhan university, preservation number CCTCC NO: m2020340.
Drawings
FIG. 1 shows a map of pAMEXloxp-1 vector;
FIG. 2 shows the determination of the absolute configuration of L-piperazinoic acid produced by the microorganism strain of the present invention; wherein A is an FDAA derivatization liquid phase diagram of an L-piperazinic acid standard product; b is an FDAA derivatization mass spectrogram of an L-piperazinic acid standard product; c is a liquid phase diagram of L-piperazine acid FDAA derivatization produced by the microbial strain; d is an FDAA derivatization mass spectrogram of L-piperazinic acid produced by the microbial strain;
FIG. 3 shows the production of L-piperazinoic acid by the microorganism strain of the present invention 1 H NMR spectrum;
FIG. 4 shows the production of L-piperazinoic acid by the microorganism strain of the present invention 13 C NMR spectrum;
FIG. 5 shows a HMBC spectrum of L-piperazinoic acid produced by the microbial strain of the invention;
FIG. 6 shows HSQC spectra of L-piperazinic acid produced by the microbial strains of the present invention;
FIG. 7 shows the LC-MS detection results of L-piperazinoic acid Fmoc-Cl derivatization by the microbial strains of the present invention;
FIG. 8 shows the L-piperazinic acid production in iron deficiency medium and iron deficiency medium by microbial strains DFK1 and DFAK1 of the present invention.
Detailed Description
The invention discloses a microbial strain for efficiently synthesizing L-piperazine acid and a construction method and application thereof. It is expressly intended that all such similar substitutes and modifications apparent to those skilled in the art are deemed to be included in the invention. The microorganism strains and the construction methods and applications thereof have been described in the preferred embodiments, and it is obvious to those skilled in the art that the technology of the present invention can be implemented and applied by modifying or appropriately changing and combining the microorganism strains and the construction methods and applications thereof without departing from the content, spirit and scope of the present invention.
The nucleic acid fragment, primer probe, reagent and the like used in the present invention can be synthesized and purchased by a reagent company.
The main experimental materials used in the examples of the invention are as follows:
the HN6.2 strain is preserved in China center for type culture Collection, and the DF1 strain is preserved in a preservation No. CCTCC NO: knock-out of ornithine carbamoyl transferase gene OTC, L-ornithine-N5-transacetylase gene sidL, FC synthetase gene sidC and L-ornithine-N on the basis of Aureobasidium melanogenin HN6.2 strain of M2020340 5 -the hydroxyl-transacetylase gene sidF.
Escherichia coli competence DH5 alpha, pMD19-T Simple vector purchased from Takara Bio Inc.; the map of the expression vector pAMEXloxp-1 is shown in figure 1, and the whole gene sequence is shown in SEQ ID NO. 7.
T4DNA ligase, restriction enzymes (SpeI, SalI and SmaI), DNA polymerase were purchased from Dalibao Bio Inc.
Plasmid DNA extraction kit and PCR purification kit were purchased from TSINGKE.
LB culture medium: 10g/L tryptone, 5g/L yeast extract powder and 10g/L sodium chloride, fully dissolving in deionized water, naturally adjusting the pH value, and adding 20g/L agar powder into a solid culture medium; autoclaving at 115 deg.C for 30 min; ampicillin was added at a final concentration of 100.0. mu.g/mL prior to use.
YPD medium: fully dissolving 20g/L peptone, 10g/L yeast extract and 20g/L glucose in deionized water, naturally adjusting the pH value, and adding 20g/L agar powder into a solid culture medium; autoclaving at 115 deg.C for 30min
Iron deficiency medium (MSP medium): 10-30g/L glucose, 1-5 g/L ammonium sulfate, 1-4 g/L dipotassium hydrogen phosphate, 1-2 g/L citric acid monohydrate, 1-5 g/L YNB, 0.01-0.1 g/L magnesium sulfate, 0.001-0.005 g/L zinc sulfate, pH 6-7, pH 6.5 adjustment, and autoclaving at 115 ℃ for 30 min. All glassware used in the preparation process needs to be soaked in 6.0N hydrochloric acid solution overnight, and then washed for several times by distilled water to remove iron attached to the glassware and avoid interference to experiments.
Piperazine acid production medium (CM medium): 10-50 g/L glucose, 10-30g/L peptone, 1-5 g/L dipotassium hydrogen phosphate, 1-2 g/L citric acid monohydrate, 1-5 g/L YNB, 0.01-0.1 g/L magnesium sulfate, 0.001-0.005 g/L zinc sulfate, and pH 6-7. Autoclaving at 115 deg.C for 30 min.
The invention is further illustrated by the following examples.
Example 1: transformation of piperazine synthase genes of different origins
Constructing a yeast strain expressing a piperazine synthase gene comprises:
six L-piperazine synthetase homologous genes from different sources obtained by NCBI are subjected to codon optimization and sent to a company for synthesis. Obtaining a series of recombinant plasmids after vector construction; the respective recombinant plasmids were transformed into DF1 strains, respectively, to obtain a series of strains expressing different sources of L-piperazine synthetase genes, as shown in table 1 below:
TABLE 1
Figure BDA0002860959770000061
1. Construction of recombinant plasmid:
(1) plasmids were synthesized by SalI and SpeI linearization;
(2) the linearized plasmids were ligated to the expression vector pAMEXloxp-1 by means of a recombinase, the specific procedure being as follows:
a. a connection system: pAMEXloxp-1 vector 2uL, gene fragment 15uL, Buffer 2uL, T4DNA Ligase 1 uL, and distilled water to make up to 20 uL. Mixing, reacting at 37 deg.C for 30min, and ice-cooling for 5 min.
b. The ligation products were transferred to 50. mu.L DH5a competent cells, incubated on ice for 20min, heat-shocked at 42 ℃ for 90S, added with 800. mu.L pre-cooled LB, incubated at 37 ℃ for 30min, then plated with 100ug/mL Amp resistant LB plates and incubated overnight in a 37 ℃ incubator.
c. Positive clones were picked up in LB tubes containing 100ug/mL Amp resistance and cultured overnight at 37 ℃ at 220 rpm.
d. And (3) extracting plasmids from the escherichia coli cells cultured in the test tube and sequencing. And comparing the sequencing results to obtain the correct recombinant plasmid.
And (3) transforming the series of recombinant plasmids with correct sequencing to be competent for yeast by a protoplast transformation method. And (3) coating the transformed yeast on a YPD solid culture medium containing a corresponding antibiotic for screening, culturing in an incubator at 28 ℃ for 2 days until a transformant appears, selecting a positive transformant, and performing subsequent fermentation after re-screening.
2. Transformation of recombinant plasmids
Protoplast transformation of a Strain
(1) A single colony of the Δ sidA strain activated for 48h on a YPD plate was inoculated into 50mL of HC liquid medium and cultured at 28 ℃ for 12h with shaking at 180 rpm.
(2) After microscopic examination to confirm no infectious microbes, 25mL of the bacterial solution containing more yeast-like bacteria is put into a sterile 50mL centrifuge tube, 8000 Xg is carried out, and the bacteria are centrifuged for 5min at room temperature and collected.
(3) The cells were resuspended in 30mL sorbitol-trisodium citrate buffer, 8000 Xg, centrifuged at room temperature for 5min, and collected.
(4) The cells were resuspended in 5mL sorbitol-trisodium citrate buffer, 1mL of digesting enzyme and 1mL of collapsing enzyme (supernatant was centrifuged before use) were added, and the cells were disrupted at 22 ℃ and 100rpm for 30-60 min.
(5) The treated cells were subjected to microscopic examination, and after confirming cell wall rupture, 3000 Xg was centrifuged for 5min to collect cells.
(6) The cells were resuspended in 30mL of STC buffer, 3000 Xg, centrifuged for 5min, and the supernatant was discarded.
(7) The cells obtained in the previous step were resuspended in 6mL of STC buffer, centrifuged at 3000rpm for 5min at room temperature, and the cells were collected.
(8) 1.5mL of STC buffer solution is taken to resuspend the thalli, and the competent cells are obtained.
(9) Add 50. mu.L of linearized fragment and 50. mu.L of PTC solution to 200. mu.L of competent cells in 1.5mL sterile centrifuge tube and mix well. Water bath at 22 deg.c for 10 min. Blank control group was not added with linearized fragments.
(10) Adding PTC buffer solution 50 μ L, 200 μ L, and 800 μ L into the mixture 3 times at 1min interval, and mixing gently.
(11) Keeping the temperature in a water bath at 22 ℃ for 1h, then centrifuging at 3000 Xg and 22 ℃ for 15min, and removing the supernatant.
(12) The cells were resuspended in 1mL of 2 XHCS buffer, 2000 Xg, and centrifuged at 22 ℃ for 15min to collect the cells.
(13) After resuspending the cells in 0.5mL of 2 XHCS buffer, the cells were cultured at 28 ℃ and 100rpm for 1 hour to double the cell walls. The cells after the wall covering are coated on a double-layer HCS solid culture medium (hygromycin B or nourseothricin with the concentration of 50 mu g/mL is added in the lower layer, and antibiotics are not added in the upper layer), and are statically cultured for 48 hours at 28 ℃.
(14) The transformants were picked and inoculated on YPD solid medium at 100. mu.g/mL hygromycin B or nourseothricin, and left to stand at 28 ℃ for 36 hours. And (4) preserving the transformant obtained by re-screening for the next screening and verification step.
Introducing each expression plasmid into DF1 by standard protoplast transformation method, fermenting by CM culture medium, carrying out Fmoc-CL derivatization on the fermentation product, and finally, observing whether a new peak corresponding to a standard product is generated by HPLC analysis, thereby preliminarily judging whether the transformed piperazine synthetase gene is the required target gene.
3. Fermentation product determination and screening of Yeast transformants
(1) The high performance liquid chromatography analysis method after fermentation product FDAA derivatization comprises the following steps:
flow rate: 0.5 mL/min;
wavelength: 340 nm;
column temperature: 30 degrees;
column: c18 water phase column;
the loading program settings are shown in table 2 below;
TABLE 2
Figure BDA0002860959770000081
(2) The high performance liquid chromatography analysis method after the fermentation product Fmoc-Cl derivatization comprises the following steps:
flow rate: 1 mL/min;
wavelength: 280 nm;
column temperature: 28 degrees;
column: phenomenex Luna C18 column (5 μm,4.6mm ID. times.250 mm);
the loading program settings are shown in table 3 below;
TABLE 3
Figure BDA0002860959770000082
(3) The highest yield of the piperazine synthetase gene KtzT is obtained by HPLC detection after the fermentation product Fmoc-CL derivatization (the result is shown in Table 4).
TABLE 4
Figure BDA0002860959770000083
Figure BDA0002860959770000091
(Note: Aureobasidium melanogenesis DOLCF, i.e., DF1 strain: a strain in which OTC, sidL, sidC and sidF were knocked out for the Aureobasidium melanogenesis original strain in order to accumulate more piperazinic acid precursors; strain DFK1-DFK 6: DF1 strain transformed with piperazinic acid synthase genes from different sources as shown in Table 1; DFAK1 strain DF1 was continuously knocked out for relieving iron ion inhibition 5 Hydroxylase gene sidA, followed by co-expression of sidA provided according to the invention and piperazine acid synthesis gene ktzT, resulting in strain DFAK 1. )
As is apparent from Table 3, the highest yield of crude piperazinic acid was 63.61mg/L for the strains derived from the L-piperazinic acid synthetase genes, which is far less than 152.98mg/L and 179.37mg/L for the strains of the present invention (DFK1 and DFK2), and the microbial strains DFK1 and DFK2 of the present invention have a very significant advantage in yield as compared with yeast strains derived from the L-piperazinic acid synthetase genes, which also indicates that the L-piperazinic acid synthetase genes derived from different sources are greatly different from each other in yield.
(4) Separation and purification and nuclear magnetic identification
The derivatized crude product was further purified by semi-preparative liquid phase according to HPLC procedure after derivatization of the conversion product Fmoc-Cl as in example 1, wherein the liquid feed was 200uL, using an elette C18 reverse phase preparative column. Manually intercepting a peak at a target position, connecting an EP tube every 1mL after the target peak appears, then detecting by HPLC analysis, and concentrating by a rotary evaporator to remove derivatization to obtain 11.25mg of brown solid.
The obtained solid is treated with D 2 Dissolving O, moving to a sample bottle, and carrying out nuclear magnetic detection. The detection items include one dimension ( 1 H、 13 C) And two-dimensional (COSY (H-H), HMBC, HSQC). The L-piperazinoic acid is determined by mass spectrometry, nuclear magnetic resonance and liquid phase absolute typing (see the description in FIGS. 2 to 7).
Example 2: construction of SidA-KtzT Co-expression Strain
Constructing a recombinant plasmid pAMEXloxp-1-SidA-KtzT containing an L-ornithine hydroxylase coding gene SidA and an L-piperazine synthetase coding gene ktzT according to the method;
the constructed recombinant plasmid pAMEXloxp-1-SidA-KtzT is transformed into DF1 host bacteria of which the original SidA is knocked out by an electrotransformation method, and the DF1 host bacteria are coated on a YPD solid medium plate containing corresponding antibiotics and cultured overnight at 28 ℃ to construct a genetic engineering bacterium DFAK 1.
DFAK1 was fermented in CM medium for 5 days, and the piperazine acid yield was 694.87. + -. 41.36mg/L by HPLC, and the results are shown in Table 3.
Example 3: effect of iron ion on piperazine acid production
In order to verify whether the strain DFAK1 is relieved of iron ion inhibition, in the experiment, the yields of piperazine acid were measured after fermentation of DFK1 and DFAK1 in MSP medium and high-iron medium (adding ferric chloride with a final concentration of 10 μ M based on MSP) for 5d and 120h, respectively, and the results are shown in FIG. 8, from which it can be seen that the strain DFAK1 is completely relieved of iron ion inhibition.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Sequence listing
<110> China oceanic university
<120> microbial strain for efficiently synthesizing L-piperazinic acid, and construction method and application thereof
<130> MP2014736
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 660
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgttcgtcc ctggcccata ccacgctcct gaggatcgct ggctcgtcga tcttgtccgt 60
ggtcacccac tggctcagct cgcttctaac ggtgctggtg gtgctgctcc acacatcacc 120
cacgtcccaa tcatcgtcga tcccgagctt gatggtcctg tcgatcgcct cgtcggcatc 180
actctttggg gtcacatgaa ccgtgctaac cctcactggg ctgctcttgg tggtgctgct 240
aacgtcgtcg ctaccttcgc cggcccaaac gcttacgtct ctcccgccgt ctacagaact 300
gctcccgctg cccctacctg gaacttcact tctgtccagg tccgtggcga gcttagaaag 360
gtcgagtctg ccgacgatac cctggctact gtccgtgcca ccgtcgctgc cctcgagtct 420
agattcggcg ctggttggga tatgactggc tctctggact acttccgtcg tatcctccca 480
ggtgtcggtg ccttcagact tcgcgtcgct gaggccgatg gcatgttcaa gctgtctcaa 540
gagcagcaac ctgccatcag acgccgtgtc cgccactctt tcggcggttg cgaggctacc 600
agagctgtcg ccggccttat ggaccgcctg cctactgagc accaccacca ccaccactaa 660
<210> 2
<211> 645
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
atgttcgtcc cttctcacta ccgcgagcca gactcttctt ggatggtcga tatcatccgt 60
ggcaacccac tggccctcat gatgtctaac ggtgctgctg gcgagcctcc attcgctacc 120
caccttcctg tcatccccga ccctgctatg actggcgatt ggtctgagag actgtctgag 180
gccaccctcc ttggtcacat gaaccgcgat aaccctcagt ggcaggcttt ggaggatggt 240
gctgtcgtca gaatcgcttt ctctggtccc cacgcttacg tctctcctac cctttacggc 300
gtcactccag ctgcccccac ctggaacttc acttctgtcc acgtccgtgg tgtcgtcgag 360
agaatccctt ctaccgagga gactcttgag gtcgtcaagt ctactgtccg tgctttcgag 420
gccgacttcg gcgagggttg ggatatggct gcctctatcg actacttcag aaagatcgtc 480
cctggcgtcg gtgccttccg catcatggtc cgtaacgtcg atggcatgtt caagctgtct 540
caggagcagc aaccagaggt ccgcgaccgt gtcagaaagt ctttcgctgg cagagagtgc 600
ggtcgccacc aagagaccgc tgcctacatg tctcgtctcc cataa 645
<210> 3
<211> 696
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
gtctacgagc gccctcttta ccgtgaggac tgcgatggtg tcgtcctcgc cttccttcgc 60
cacaacccac tggctatggt cgtcacttct cacgacgatg tccctgtcgc cacccacgct 120
ccagtcctct tccgtcacgg tccagatggt gctgatgctg aggctgtcgc tgctggtact 180
gtcccactgg ctggttctac cctcatcggc cacatgaacg tcgagaaccc tcagtggcgc 240
cgtatgagat ctggcgaccg cgctcttatc gtcttccaag gtccccacgg ctacgtctct 300
cctaccgtct acggtgtcac tcccgctgcc cctacctggg acttcatcgc tgtccatgtc 360
aacggtactg tcgagccaac tgctgatccc gctgccgtcc tcgacatcgt ctctgatact 420
gctagacgcc ttgagtctgg cttcggtcgt ggctgggacc aggagtcttc tctcgattac 480
ttcagacaaa tcgcccctgg tgtcggcgct ttcactctgc gcgtcgattc tgtccagacc 540
atgttcaagc tctctcaaga gaagcctgcc ccaatgcgta gacgcgtcgt cgagcagttc 600
gaggcttctg agtctggcac ccaccgtgcc cttgcttctg tcatgcgtga cagaggtctg 660
actgaggccg atgaggagag agagaccgct ggctaa 696
<210> 4
<211> 672
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgttcgtcc cacagcacta cagaactgat gatcgccgtt ggcctgtccg tatcgtccaa 60
gacaaccctc tcgctctcct tatgtctacc cgcgatggcc gtgctccttt cgcctctcac 120
gtcccagtca tcgtccttcc cagacagcgc gaggagctgg agagaactgg ccgctggcaa 180
ggtgctgtcc tccacggtca catgaacaga gccaacccac actggaagtc cttggctgat 240
ggtcagcctg ctggtcttgt cttccaaggc cctgctggtt acgtctctcc agccgtctac 300
aacacctctc ccgctgtccc tacttggaac ttcactgctg tccatgtcca gggccgcctg 360
aagctcgtcg ctgacgagga agctactctt ggtgtcgtct ctgctactgc tagacagctg 420
gaggagagat tcggtgctag atggactgtc gagccttctg tcgatcactt ccgtcaaatc 480
ctgccaggcg tcggtgcctt cgagctcaga gtcgaggagt gcgactctat gttcaagctc 540
tctcaagaga aggagcacga agtcagacac gctgtcatgg attggtgcgc ccgctctccc 600
cgtggtagat ctaacgacct tgctgccgtc atgcgtgatt actaccctcc aaccactacc 660
tggccttctt aa 672
<210> 5
<211> 711
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
atgttccgcc gtagaggtgt cacccttact aaggctctcc ttaccgccgt ctgcatgctg 60
gctgccccac tcactcaggc tatctctgtc ggcaacctta ccttctctct gccctctgag 120
actgacttcg tctctaagcg tgtcgtcaac aacaacaagt ctgccagaat ctaccgcatc 180
gctatctctg ccatcgactc tccaggttct tctgagctca gaactagacc tgtcgatggt 240
gaactgctct tcgctcctag acagctcgct cttcaagccg gcgagtctga gtacttcaag 300
ttctactacc acggccccag agataaccgt gagagatact accgtgtctc tttcagagag 360
gtcccaaccc gcaaccacac tcgccgttct cccaccggcg gtgtcgtctc tactgagcct 420
gtcgtcgtca tggacaccat cctggtcgtc cgccctcgtc aggtccaatt caagtggtct 480
ttcgataagg tcaccggcac tgtctctaac accggtaaca cttggttcaa gcttctgatc 540
aagcctggct gcgactctac tgaggaagag ggcgatgctt ggtacttgcg cccaggcgat 600
gtcgtccacc agcccgagct ccgtcaacct ggtaaccact accttgtcta caacgacaag 660
ttcatcaaga tctctgattc ttgcccagct aagcctccat ctgccgatta a 711
<210> 6
<211> 678
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atggtcgtcg gtatgaccgc tgagacctct actgtccagg gcgctctttt cggtgaccct 60
gccgtcatcg agaccactga tcacggccct accgccactc aggacccacg tgaggtcgct 120
agagtcgtcg gccttgccca agatccaggt ctgttcgtcg tcgagagaac tggtcttgtc 180
ctgcgcgctg atccagctag acctggttgc gctgatgctc tggctcgtca cgacggtgat 240
accgtcgctc aactccttga tactggccac ctcagacttg gcggtaccca ccatgtccat 300
cacaacggtg atgagggtcc agctcgttct gtcctcgtcc ctaaggccac tagagacatg 360
gtctctcgct gggatcacct tcgtcctatc ccagagccca ccagagctcc tgagccaact 420
aaggccccac agagatctac tggtctcatc ggtgtcgatg tcgtcgagcc tggcaaggct 480
ctggtctgct tgggtaccac tggtcaaggc ggtactgtcc tgcgcgatgg cggtagatac 540
cgcgtcgaga acgaccatgg tgctttggtc ggtcatgctt cttcttaccg cgctgccgct 600
cgtctgctcg ctagatacca cggctacgcc cccggtcctg tcgagatcga gcacgagcac 660
cgtcttcacc gccgttaa 678
<210> 7
<211> 5424
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
gacgaaaggg cctcgtgata cgcctatttt tataggttaa tgtcatgata ataatggttt 60
cttagacgtc aggtggcact tttcggggaa atgtgcgcgg aacccctatt tgtttatttt 120
tctaaataca ttcaaatatg tatccgctca tgagacaata accctgataa atgcttcaat 180
aatattgaaa aaggaagagt atgagtattc aacatttccg tgtcgccctt attccctttt 240
ttgcggcatt ttgccttcct gtttttgctc acccagaaac gctggtgaaa gtaaaagatg 300
ctgaagatca gttgggtgca cgagtgggtt acatcgaact ggatctcaac agcggtaaga 360
tccttgagag ttttcgcccc gaagaacgtt ttccaatgat gagcactttt aaagttctgc 420
tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga gcaactcggt cgccgcatac 480
actattctca gaatgacttg gttgagtact caccagtcac agaaaagcat cttacggatg 540
gcatgacagt aagagaatta tgcagtgctg ccataaccat gagtgataac actgcggcca 600
acttacttct gacaacgatc ggaggaccga aggagctaac cgcttttttg cacaacatgg 660
gggatcatgt aactcgcctt gatcgttggg aaccggagct gaatgaagcc ataccaaacg 720
acgagcgtga caccacgatg cctgtagcaa tggcaacaac gttgcgcaaa ctattaactg 780
gcgaactact tactctagct tcccggcaac aattaataga ctggatggag gcggataaag 840
ttgcaggacc acttctgcgc tcggcccttc cggctggctg gtttattgct gataaatctg 900
gagccggtga gcgtgggtct cgcggtatca ttgcagcact ggggccagat ggtaagccct 960
cccgtatcgt agttatctac acgacgggga gtcaggcaac tatggatgaa cgaaatagac 1020
agatcgctga gataggtgcc tcactgatta agcattggta actgtcagac caagtttact 1080
catatatact ttagattgat ttaaaacttc atttttaatt taaaaggatc taggtgaaga 1140
tcctttttga taatctcatg accaaaatcc cttaacgtga gttttcgttc cactgagcgt 1200
cagaccccgt agaaaagatc aaaggatctt cttgagatcc tttttttctg cgcgtaatct 1260
gctgcttgca aacaaaaaaa ccaccgctac cagcggtggt ttgtttgccg gatcaagagc 1320
taccaactct ttttccgaag gtaactggct tcagcagagc gcagatacca aatactgttc 1380
ttctagtgta gccgtagtta ggccaccact tcaagaactc tgtagcaccg cctacatacc 1440
tcgctctgct aatcctgtta ccagtggctg ctgccagtgg cgataagtcg tgtcttaccg 1500
ggttggactc aagacgatag ttaccggata aggcgcagcg gtcgggctga acggggggtt 1560
cgtgcacaca gcccagcttg gagcgaacga cctacaccga actgagatac ctacagcgtg 1620
agctatgaga aagcgccacg cttcccgaag ggagaaaggc ggacaggtat ccggtaagcg 1680
gcagggtcgg aacaggagag cgcacgaggg agcttccagg gggaaacgcc tggtatcttt 1740
atagtcctgt cgggtttcgc cacctctgac ttgagcgtcg atttttgtga tgctcgtcag 1800
gggggcggag cctatggaaa aacgccagca acgcggcctt tttacggttc ctggcctttt 1860
gctggccttt tgctcacatg ttctttcctg cgttatcccc tgattctgtg gataaccgta 1920
ttaccgcctt tgagtgagct gataccgctc gccgcagccg aacgaccgag cgcagcgagt 1980
cagtgagcga ggaagcggaa gagcgcccaa tacgcaaacc gcctctcccc gcgcgttggc 2040
cgattcatta atgcagctgg cacgacaggt ttcccgactg gaaagcgggc agtgagcgca 2100
acgcaattaa tgtgagttag ctcactcatt aggcacccca ggctttacac tttatgcttc 2160
cggctcgtat gttgtgtgga attgtgagcg gataacaatt tcacacagga aacagctatg 2220
accatgatta cgccaagctt gcatgccccg gggctaaaaa ccccaacttc ggaaaggggt 2280
gtatttatta gataaaaaac caacgccttt cggggctcct tggtgattca taataactaa 2340
acgaatcgca tggccttgcg ccggcgatgg ttcattcaaa tttctgccct atcaactttc 2400
gatggtagga tagtggccta ccatggtatc aacgggtaac ggggaattag ggttctattc 2460
cggagaggga gcctgagaaa cggctaccac atccaaggaa ggcagcaggc gcgcaaatta 2520
cccaatcccg acacggggag gtagtgacaa taaatactga tacagggctc ttttgggtct 2580
tgtaattgga atgagtacaa tttaaatccc ttaacgagga acaattggag ggcaagtctg 2640
gtgccagcag ccgcggtaat tccagctcca atagcgtata ttaaagttgt tgcagttaaa 2700
aagctcgtag ttgaaccgac agttggctca tcatccgtta catcatcttt ttttctgctg 2760
gctccgctcg gtgggctccc aacgaagcag caaaaaaagt gagagagaaa aactagcttg 2820
gcggggcatc cgaagctaga ccctttggct cgcttagtca gtgcgccctc tcacacacac 2880
tcaaaaaggc cacccctccc gcaccctctt ctcatcaccg tcttcatacc acggttcgtc 2940
aagcaatcgt atctggtaag ctttgacctc ttgagcgggc tccactttgc tatttcttgg 3000
atctgctcat tcttttcttc cttcctctct ttctaacctc tcttcagaaa gttcaaccgt 3060
acttcactca atcttccata catcaccgtc aaacactagt cttaagatgc atacgcgtga 3120
gctcctgcag ggtaccgtcg actaccgttc gtatagcata cattatacga agttattaat 3180
tcgggggatc tggattttag tactggattt tggttttagg aattagaaat tttattgata 3240
gaagtatttt acaaatacaa atacatacta agggtttctt atatgctcaa cacatgagcg 3300
aaaccctata ggaaccctaa ttcccttatc tgggaactac tcacacatta ttatggagaa 3360
actcgagctt gtcgatcgac agatcccggt cggcatctac tttatggaca tggcatggac 3420
atgtacaaag cctgttcacc atcagaagca gtaccgtcgt acaaagcagt atccaaacca 3480
cacaaggtga aacccattct tctgtaagcg tggatagctg gagcgttgac gttggtaacc 3540
tccaaccaca agtgaccagc acctctctct ctagcgaact cagtagccaa acccatcaaa 3600
gctctaccga caccgtgacc tctgtgttct ggagcgacct cgatgtcttc aacggtcaat 3660
cttctgttcc aaccggagta agagacaacg acgaaaccag ccaaatcacc atcgtcaccg 3720
taagcgacga aagttctgga gtctggatca ccgtcctcac cagcgtcgga ctcatcgtca 3780
gattcatcgt ctgggaaaac cttggtcaat ggtggatcga ctggaacttc tctcaaagtg 3840
aaaccgtcac cagtagcggt gactctgaaa acagtatcag tggtgaagga accgtccaaa 3900
gcctcgatag cttcagcatc acctggaaca gaagttctgt atctgtaagc ggtatcgtcc 3960
aaagtggtca ttgtgactga attggatgtg ttagacaggt tgatgtgaac gacagcaaca 4020
gagaaagacg cacagagtta tatacaacag agcttgatgg gttgttgtgg tgtgtgaggg 4080
gcttgaatct ttccccaaca gcttccgacg ctcggcatga ggggcagctc aaaaaaaccg 4140
cgtcaccgac gtgctaccga gatcttcgtg ctctctcgtg tttgcctatc aactgatatc 4200
accaatcatg agccatctct atgtacaaac tgcccttgga tcacgtgctt cactcgacat 4260
ctgcaccatg tatccttctt cgaattgctc atcttgatca ctttattatt caagatgcct 4320
tgcaccacac gacatgtcta tcgatcggcc cgtaacgccc cgtgaagttg ccagaacgcc 4380
tgcctgtccc gctgtccgat ggatgcatga aggtaatata acttcgtata gcatacatta 4440
tacgaacggt aggatcccca acagggattg ccctagtaac ggcgagtgaa gcggcaacag 4500
ctcaaatttg aaagctggcc ttcgggtccg cattgtaatt tgtagaggat gctttgggtg 4560
aaacgccagt ctaagttcct tggaacagga cgtcatagag ggtgagaatc ccgtatgtga 4620
ctggaaatgt taacctatgt aaagctcctt cgacgagtcg agttgtttgg gaatgcagct 4680
ctaaatggga ggtaaatttc ttctaaagct aaatattggc gagagaccga tagcgcacaa 4740
gtagagtgat cgaaagatga aaagcacttt ggtaagagag ttaaaaagca cgtgaaattg 4800
ttgaaaggga agcgcttgca atcagacttg tttaaactgt tcggccggtc ttctgaccgg 4860
tttactcagt ttggacaggc cagcatcagt ttcggcggcc ggataaaggc tttgggaatg 4920
tggccttcac ttcggtgaag gtgttgtagc ccagggtgta atacggccag ccgggactga 4980
ggtccgcgct tcggctagga tgctggcgta atggttggaa ttccccggga ctggccgtcg 5040
ttttacaacg tcgtgactgg gaaaaccctg gcgttaccca acttaatcgc cttgcagcac 5100
atcccccttt cgccagctgg cgtaatagcg aagaggcccg caccgatcgc ccttcccaac 5160
agttgcgcag cctgaatggc gaatggcgcc tgatgcggta ttttctcctt acgcatctgt 5220
gcggtatttc acaccgcata tggtgcactc tcagtacaat ctgctctgat gccgcatagt 5280
taagccagcc ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct tgtctgctcc 5340
cggcatccgc ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt cagaggtttt 5400
caccgtcatc accgaaacgc gcga 5424
<210> 8
<211> 1461
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
atgtcccgac tgacacaatc caaagaagaa agaaagataa tcaacacaat ggcacctcac 60
gccgacattt ccgaaattgc tctcgagagc gtcccagagc gcaatggctc cagattcaaa 120
acacacctcc agtcaacacc acagaacgac gtgcacgatg tagtctgcat tggcttcggt 180
tctgcctcgc tggcaatcgc agttgccctc cacgatgcga ccaagcagac gggcaagcag 240
ccaccacaac tcagaacaca acccaaggtc gccttcctcg agaagcaaga gacgttcgca 300
tggcacgctg gcatgcagat tcctggtgcc aagatgcaaa tctcgttcat caaggacatg 360
gccaccatgc gcaaccctcg cagcgagttc accttcctca actacctgca cgagaacgac 420
cgcctggtgc agttcaccaa cctcagcact ttcctgcctc ggcgcattga gttcgaggac 480
tatctccgct ggtgtgccgg ctggttccag aacctggttt catatggtca agaggtggtc 540
gatatctcgc ctgacacgca ggccaagagt gcagagggtg tgacaacgtg gacaatcaca 600
tctcgcaacc ttcacaccaa cgaactcagc ttccgccgca cgaaacgcgt tgtcgttgct 660
gtcggaggtc acccaagaat cccagaggcc ttccctcaac accacccccg tgtcctccac 720
tcgtcgcaat actggactct ctcgtcccgc atcttccgcg accgtaatgc tcctctcaaa 780
atcgccgtca ttggctctgg tcaatccgct gccgagatct tcatgaactt gcccagccaa 840
ttccccaact ccaaagccta cctcatgatc agaggcgctg ccctcagacc ttcggatgac 900
tcgcctttcg tcaacgaagt cttcgacccc gagcgtacta atgacacctt cagtcaagat 960
cctgagatcc gtgccgcagc catcaagatg gacaaggcca ccaactacgg tgtcgttcgt 1020
ctcgagctgc tggagcacat gtatgatgtc ctctatacac aacgcctcaa ccacggcgac 1080
gatgaggaga actggcccca acgcctgctc aactaccgcg aagtcgagag tgtgaccgaa 1140
ttgcccgacg accgtgtccg actccacatc agaaacgata cctcgaagca cagatgtcgc 1200
aagagctcta cgaaagagac tctggatgtg gatctggtca tgatcgccag cggatacaga 1260
agagatcacc acgagcagtt gttgtccaag gtcagaccca tgatgcccgg tggggacaag 1320
cctggtcaga agtggaccgt caaccgcgaa tacaaggtcg agtttgagca gggcactgtc 1380
gcaaaggact ctggtgtctg gttgcaggga tgtaacgaga gtacccacgg tgtaagtttt 1440
ggtccaacct tcgcttcgtg a 1461

Claims (8)

1. A microbial strain for efficiently synthesizing L-piperazinic acid is characterized in that a carrier containing an L-piperazinic acid synthetase encoding gene ktzT or hmtC is further transformed in a aureobasidium melanoidinum D-OLCF strain, or the L-piperazinic acid synthetase encoding gene ktzT or hmtC is integrated into a genome of the aureobasidium melanoidinum D-OLCF strain;
the coding gene ktzT of the L-piperazine synthetase is derived from Kutzneria sp.744;
the gene hmtc encoding the L-piperazine synthetase is derived from Streptomyces himastatinicus ATCC 53653;
the aureobasidium pullulans D-OLCF is a compound with the preservation number of CCTCC NO: knock-out of ornithine carbamoyl transferase gene OTC and L-ornithine-N on the basis of Aureobasidium melanogenin HN6.2 strain of M2020340 5 Transacetylase gene sidL, FC synthetase genesindC and L-ornithine-N 5 -a strain of the hydroxy-transacetylase gene sidF.
2. The microorganism strain according to claim 1, further comprising a vector comprising a gene sidA encoding L-ornithine hydroxylase shown in SEQ ID NO. 8, which is obtained by knocking out the gene sidA encoding the original L-ornithine hydroxylase in the aureobasidium pullulans D-OLCF producing strain; or replacing the original gene sidA encoding the L-ornithine hydroxylase by the gene SidA encoding the L-ornithine hydroxylase shown in SEQ ID NO. 8 in the genome of aureobasidium pullulans D-OLCF.
3. Use of the microorganism strain according to claim 1 or 2 for the fermentative production of L-piperazinoic acid or for the preparation of a microbial product for the fermentative production of L-piperazinoic acid.
4. The method for constructing a microorganism strain according to claim 1, wherein the microorganism strain is obtained by constructing a vector containing the gene ktzT or hmtc encoding L-piperazinic acid synthetase and then transforming the vector into a strain producing aureobasidium melanophore D-OLCF.
5. The construction method according to claim 4, wherein the vector is pAMEXloxp-1 plasmid, and the whole gene sequence is shown in SEQ ID NO. 7.
6. The construction method according to claim 4 or 5, further comprising knocking out the gene sidA encoding L-ornithine hydroxylase present in the aureobasidium melanophore D-OLCF strain and converting the vector containing the gene sidA encoding L-ornithine hydroxylase as shown in SEQ ID NO. 8; or replacing the original L-ornithine hydroxylase coding gene sidA with the L-ornithine hydroxylase coding gene SidA shown in SEQ ID NO. 8 in the aureobasidium pullulans D-OLCF genome.
7. A method for producing L-piperazinic acid by fermentation, comprising inoculating the microorganism strain of claim 1 or 2 to a piperazinic acid-producing medium to produce L-piperazinic acid by fermentation.
8. The method of claim 7, wherein the piperazinoic acid producing medium is CM medium.
CN202011562000.2A 2020-12-25 2020-12-25 Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof Active CN112662573B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011562000.2A CN112662573B (en) 2020-12-25 2020-12-25 Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011562000.2A CN112662573B (en) 2020-12-25 2020-12-25 Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof

Publications (2)

Publication Number Publication Date
CN112662573A CN112662573A (en) 2021-04-16
CN112662573B true CN112662573B (en) 2022-08-16

Family

ID=75409048

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011562000.2A Active CN112662573B (en) 2020-12-25 2020-12-25 Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof

Country Status (1)

Country Link
CN (1) CN112662573B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107119065B (en) * 2017-04-27 2019-06-14 重庆大学 It is a kind of for producing the recombinant plasmid, engineering strain and method of piperidinecarboxylic acid
US20190002936A1 (en) * 2017-06-30 2019-01-03 Washington University Transgenic microorganisms and synthesis of piperazic acid, piperazic acid containing products, and derivatives thereof
CN110343728B (en) * 2019-06-04 2021-10-08 浙江大学 Method for synthesizing hexahydropyridazine-3-carboxylic acid through biotransformation

Also Published As

Publication number Publication date
CN112662573A (en) 2021-04-16

Similar Documents

Publication Publication Date Title
CN1930299B (en) Nitrile hydratase of rhodococcus
CN102146371B (en) High glyphosate resistant variant gene and improvement method and application of high glyphosate resistant variant gene
CN108949721B (en) Recombinant strain for expressing phospholipase D and application
KR20130098089A (en) Novel polypeptide binding with interleukin-6
CN109385378B (en) Increasing ginsenoside production by improving protein folding mechanism of yeast
CN112251464B (en) Gene point mutation induction method
CN111748546B (en) Fusion protein for generating gene point mutation and induction method of gene point mutation
CN108586571B (en) Novel antimycin derivative and preparation method and application thereof
CN114317584B (en) Construction system of novel transposon mutant strain library, novel transposon mutant library and application
CN103911334A (en) Clostridium beijerinckii with high stress resistance and application thereof
CN107058367A (en) The construction method of the recombined bacillus subtilis of high yield Pullulanase
CN101157935A (en) Novel expression enzyme yeast gene engineering system
CN112662573B (en) Microbial strain for efficiently synthesizing L-piperazinic acid and construction method and application thereof
CN105567603B (en) A method of Clostridium beijerinckii is improved to 4- hydroxycinnamic acid resistance
KR102064475B1 (en) Microorganism for producing muconic acid and method for manufacturing the strain
CN111471635B (en) Method for increasing content of nucleic acid in bacillus subtilis
CN108611312B (en) New antimycin biosynthesis pathway ketoreductase gene deletion strain, construction method and application
CN110066801A (en) Sialic acid inducing expression element and construction method in a kind of bacillus subtilis
CN111118049B (en) Plasmid vector and application thereof
CN106978445A (en) The method of the goat EDAR gene knockouts of CRISPER Cas9 System-mediateds
CN109880837B (en) Method for degrading lignin in tobacco straw
CN106676135A (en) Alb-uPA-teton lentiviral vector and preparation method and application thereof
KR101030547B1 (en) A plasmid shuttle vector
KR20210063127A (en) Microorganism for producing shikimic acid and method for producing shikimic acid using the microorganism
KR20120060603A (en) Construction of agelaxanthin A metabolic pathway and synthesis of agelaxanthin A through E.coli

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant